Abstract
Bone marrow transplant (BMT) is done by the replacement of damaged bone marrow with healthy one. These healthy bone marrow cells (BMCs) are usually collected from the crest of the Ilium in humans hence these cells are used to replace damaged ones in the treatment of bone marrow related diseases such as leukemia, aplastic anemia, congenital immunodeficiency and autoimmune diseases. Even though there are different methods, perfusion method is one of the simple, safe and less contaminated methods used to harvest BMCs and it can reduce the risk in allogenic BMT. Intra bone marrow – bone marrow transfer (IBM-BMT) is one of the best procedures for allogenic BMT. Due to enlisting of hematopoietic stem cells and mesenchymal stem cells, which are derived from donor, this method has distinguishable advantages in allogenic BMT. In this paper the perfusion method (for harvesting BMCs) and IBM-BMT (for their transplantation) have been critically reviewed and showed that both methods are together will become an effective combination in allogeneic BMT.
Keywords: Allogeneic bone marrow transplantation, bone marrow cells, human stem cells, mesenchymal stem cells, intra-bone marrow bone marrow transplantation, perfusion method.
Current Stem Cell Research & Therapy
Title:A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation
Volume: 9 Issue: 6
Author(s): Narasimhulu Korrapati and Harikrishna Y. Nanganuru
Affiliation:
Keywords: Allogeneic bone marrow transplantation, bone marrow cells, human stem cells, mesenchymal stem cells, intra-bone marrow bone marrow transplantation, perfusion method.
Abstract: Bone marrow transplant (BMT) is done by the replacement of damaged bone marrow with healthy one. These healthy bone marrow cells (BMCs) are usually collected from the crest of the Ilium in humans hence these cells are used to replace damaged ones in the treatment of bone marrow related diseases such as leukemia, aplastic anemia, congenital immunodeficiency and autoimmune diseases. Even though there are different methods, perfusion method is one of the simple, safe and less contaminated methods used to harvest BMCs and it can reduce the risk in allogenic BMT. Intra bone marrow – bone marrow transfer (IBM-BMT) is one of the best procedures for allogenic BMT. Due to enlisting of hematopoietic stem cells and mesenchymal stem cells, which are derived from donor, this method has distinguishable advantages in allogenic BMT. In this paper the perfusion method (for harvesting BMCs) and IBM-BMT (for their transplantation) have been critically reviewed and showed that both methods are together will become an effective combination in allogeneic BMT.
Export Options
About this article
Cite this article as:
Korrapati Narasimhulu and Nanganuru Y. Harikrishna, A Comprehensive Review on Perfusion Method Development for Bone Marrow Collection and Stem Cell Transplantation, Current Stem Cell Research & Therapy 2014; 9 (6) . https://dx.doi.org/10.2174/1574888X0906140930110950
DOI https://dx.doi.org/10.2174/1574888X0906140930110950 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Glioblastoma Tumor Initiating Cells: Therapeutic Strategies Targeting Apoptosis and MicroRNA Pathways
Current Molecular Medicine Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity
Current Topics in Medicinal Chemistry Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib
Current Cancer Drug Targets Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) The Disulfide Analogues of Isophosphoramide Mustard for Anticancer Therapy
Letters in Drug Design & Discovery Rho-Signaling Pathways in Chronic Myelogenous Leukemia
Cardiovascular & Hematological Disorders-Drug Targets Novel Concepts in the Development of Platinum Antitumour Drugs: An Update
Medicinal Chemistry Reviews - Online (Discontinued) The Use of Innovative Tools to Reproduce Human Cancer Translocations: Lessons from the CRISPR/Cas System
Current Biotechnology Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development
Current Topics in Medicinal Chemistry The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets The Mutator Phenotype in Cancer: Molecular Mechanisms and Targeting Strategies
Current Drug Targets Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Current Neurovascular Research Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry Environmental Factors Contributing to Susceptibility to Tuberculosis
Current Respiratory Medicine Reviews Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells
Current Pharmaceutical Biotechnology Transposons for Gene Therapy!
Current Gene Therapy